Related Experiment Video
Updated: Dec 7, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Familial Hyperckemia and Calf Hypertrophy Secondary to a Caveolin-3 Mutation
Eduardo Otero-Loperena1, Ana Ortiz-Santiago, Edwardo Ramos
1From the Physical Medicine and Rehabilitation Department, VA Caribbean Healthcare System of San Juan, San Juan, Puerto Rico (EO-L); and Physical Medicine and Rehabilitation Department, University of Puerto Rico School of Medicine, San Juan, Puerto Rico (AO-S, ER).
Insights
Idiopathic hyperckemia, characterized by elevated creatine kinase, can be a benign genetic condition. A rare caveolin gene mutation causes an autosomal dominant form of familial hyperckemia.
Area of Science:
- Genetics
- Neurology
- Biochemistry
Background:
- Idiopathic hyperckemia is defined as persistent elevation of serum creatine kinase (CK) levels, at least 1.5 times the upper limit of normal.
- This condition often presents asymptomatically or with mild symptoms like myalgias and cramps, despite normal neurological examinations.
Observation:
- Familial hyperckemia, a subset of idiopathic hyperckemia, has rarely been linked to specific genetic causes.
- This study focuses on a benign autosomal dominant condition resulting from a rare mutation in the caveolin gene.
Findings:
- The caveolin gene encodes structural membrane proteins crucial for muscle function.
- A specific, relatively unknown mutation in the caveolin-3 gene is identified as the cause of this familial hyperckemia.
Implications:
- Understanding this genetic link provides insight into the pathophysiology of familial hyperckemia.
- This research aids in the diagnosis and management of benign hyperckemia cases, distinguishing them from more severe myopathies.
Abstract:
Idiopathic hyperckemia has been described as persistent serum creatine kinase elevation at least 1.5 times the upper limit of normal in individuals with otherwise normal laboratory findings and neurological examination. This type of hyperckemia encompasses both sporadic and familial cases, which have been found to be asymptomatic or subclinical, presenting with mild symptoms, such as myalgias or cramps. Genetic causes of hyperckemia have been rarely described. The authors aim to describe a benign autosomal dominant condition caused by a rare mutation in the caveolin gene. Caveolin gene encodes for structural membrane proteins in muscle. The purpose of this article was to discuss the presentation, pathophysiology, and diagnosis of familial hyperckemia secondary to a relatively unknown mutation in caveolin-3 gene.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Kidney Disease II: Clinical Manifestations
Inborn Errors of Metabolism
Animal Mitochondrial Genetics
Cell Specific Gene Expression

